Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.
Over the last 12 months, insiders at Cyclo Therapeutics, Inc. have bought $5M and sold $0 worth of Cyclo Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Cyclo Therapeutics, Inc. have bought $1.72M and sold $522,370 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Rafael Holdings, Inc. (10 percent owner) — $5M.
The last purchase of 4,000,000 shares for transaction amount of $5M was made by Rafael Holdings, Inc. (10 percent owner) on 2023‑08‑01.
2023-08-01 | Rafael Holdings, Inc. | 10 percent owner | 4M 23.6663% | $1.25 | $5M | -1.38% | ||
2023-04-20 | FINE N SCOTT | Chief Executive Officer | 299,402 2.7233% | $0.71 | $212,575 | +105.99% | ||
2023-04-20 | Ostronic Francis Patrick | director | 59,881 0.5447% | $0.71 | $42,516 | +105.99% | ||
2023-04-20 | Sieger Markus | director | 59,881 0.5447% | $0.71 | $42,516 | +105.99% | ||
2023-04-20 | TATE JEFFREY | Chief Operating Officer | 29,941 0.2723% | $0.71 | $21,258 | +105.99% | ||
2022-09-21 | Ostronic Francis Patrick | director | 5,000 0.0594% | $1.76 | $8,800 | -14.29% | ||
2022-05-20 | Ostronic Francis Patrick | 12 0.0001% | $2.00 | $24 | -8.59% | |||
2022-05-16 | TATE JEFFREY | Chief Operating Officer | 3,000 0.0357% | $2.12 | $6,354 | -12.80% | ||
2022-04-28 | TATE JEFFREY | Chief Operating Officer | 635 0.007% | $2.50 | $1,588 | -30.00% | ||
2022-03-29 | Sieger Markus | 10,000 0.1167% | $2.73 | $27,300 | -29.50% | |||
2022-02-07 | FINE N SCOTT | Chief Executive Officer | 10,334 0.1229% | $3.58 | $36,996 | -41.90% | ||
2022-01-24 | Ostronic Francis Patrick | director | 2,000 0.0246% | $3.75 | $7,500 | -41.71% | ||
2022-01-19 | FINE N SCOTT | Chief Executive Officer | 5,000 0.0572% | $3.89 | $19,450 | -47.28% | ||
2022-01-19 | Ostronic Francis Patrick | director | 1,132 0.0133% | $4.00 | $4,528 | -47.28% | ||
2022-01-14 | Ostronic Francis Patrick | director | 3,868 0.0434% | $4.00 | $15,472 | -49.76% | ||
2021-12-15 | FINE N SCOTT | Chief Executive Officer | 5,000 0.0758% | $3.89 | $19,450 | -45.04% | ||
2021-12-15 | Ostronic Francis Patrick | director | 3,000 0.0456% | $3.90 | $11,700 | -45.04% | ||
2021-12-10 | Ostronic Francis Patrick | director | 5,000 0.0792% | $4.40 | $22,000 | -48.85% | ||
2021-12-03 | Ostronic Francis Patrick | director | 864 0.0135% | $4.75 | $4,104 | -52.83% | ||
2021-12-02 | FINE N SCOTT | Chief Executive Officer | 5,000 0.0775% | $4.93 | $24,650 | -54.81% |
Rafael Holdings, Inc. | 10 percent owner | 6514970 28.6142% | $1.22 | 1 | 0 | |
NOVIT, L.P. | 10 percent owner | 21517582 94.5068% | $1.22 | 4 | 0 | |
STRATTAN CE RICK | 19877647 87.304% | $1.22 | 2 | 5 | ||
ARMISTICE CAPITAL, LLC | 10 percent owner | 15795769 69.3761% | $1.22 | 0 | 19 | |
Farnan Joseph J Jr | director | 1340000 5.8854% | $1.22 | 2 | 0 | |
FINE N SCOTT | Chief Executive Officer | 444402 1.9518% | $1.22 | 17 | 0 | <0.0001% |
Ostronic Francis Patrick | director | 222371 0.9767% | $1.22 | 32 | 0 | <0.0001% |
Sieger Markus | director | 161051 0.7073% | $1.22 | 13 | 0 | +30.24% |
SHANAHAN WILLIAM S | director | 63677 0.2797% | $1.22 | 11 | 0 | +74.7% |
TATE JEFFREY | Chief Operating Officer | 62101 0.2728% | $1.22 | 6 | 0 | +14.85% |
Toig Randall M. | director | 34078 0.1497% | $1.22 | 5 | 0 | +74.7% |
Hrynkow Sharon Hemond | Chief Scientific Officer | 19350 0.085% | $1.22 | 6 | 0 | <0.0001% |
Fine Joshua M | Chief Financial Officer | 16900 0.0742% | $1.22 | 3 | 0 | <0.0001% |
EPIQ Capital Group | $1.19M | 2.98 | 853,815 | New | +$1.19M | 0.48 | |
Founders Fund V Management Llc | $668,184.00 | 1.68 | 480,708 | 0% | +$0 | 0.32 | |
The Vanguard Group | $551,355.00 | 1.39 | 396,658 | +11.66% | +$57,594.69 | <0.0001 | |
Geode Capital Management | $222,109.00 | 0.56 | 159,749 | +5.04% | +$10,666.86 | <0.0001 | |
Founders Fund Vi Management Llc | $152,932.00 | 0.38 | 110,023 | 0% | +$0 | 2.02 | |
State Street | $54,947.00 | 0.14 | 39,530 | +0.01% | +$6.95 | <0.0001 | |
BlackRock | $51,605.00 | 0.13 | 37,126 | -23.36% | -$15,731.98 | <0.0001 | |
Northern Trust | $30,220.00 | 0.08 | 21,741 | +24.57% | +$5,960.32 | <0.0001 | |
Renaissance Technologies | $30,000.00 | 0.08 | 21,756 | New | +$30,000.00 | <0.0001 | |
Wealth Enhancement Advisory Services LLC | $28,356.00 | 0.07 | 20,400 | +10.19% | +$2,622.93 | <0.0001 | |
Tower Research Capital | $9,149.00 | 0.02 | 6,582 | +12.11% | +$988.29 | <0.0001 | |
UBS | $6,711.00 | 0.02 | 4,828 | New | +$6,711.00 | <0.0001 | |
Wells Fargo | $6,345.00 | 0.02 | 4,565 | +91.32% | +$3,028.64 | <0.0001 | |
Morgan Stanley | $1,441.00 | <0.01 | 1,037 | +151.09% | +$867.10 | <0.0001 | |
Royal Bank of Canada | $1,000.00 | <0.01 | 746 | 0% | +$0 | <0.0001 | |
JPMorgan Chase | $213.00 | <0.01 | 153 | +750% | +$187.94 | <0.0001 | |
Qube Research & Technologies | $29.00 | <0.01 | 21 | -82.64% | -$138.09 | <0.0001 | |
Advisor Group Holdings Inc | $93.00 | <0.01 | 67 | -88.83% | -$739.84 | <0.0001 | |
Steward Partners Investment Advisory LLC | $125.00 | <0.01 | 90 | 0% | +$0 | <0.0001 | |
Bank of America | $38.00 | <0.01 | 27 | +92.86% | +$18.30 | <0.0001 |